Iguana Healthcare Management as of Sept. 30, 2016
Portfolio Holdings for Iguana Healthcare Management
Iguana Healthcare Management holds 77 positions in its portfolio as reported in the September 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ultragenyx Pharmaceutical (RARE) | 5.1 | $14M | 200k | 70.94 | |
Clovis Oncology | 4.2 | $12M | 325k | 36.05 | |
Zimmer Holdings (ZBH) | 4.0 | $11M | 85k | 130.02 | |
Alexion Pharmaceuticals | 3.3 | $9.2M | 75k | 122.55 | |
Amgen (AMGN) | 3.3 | $9.2M | 55k | 166.82 | |
Gw Pharmaceuticals Plc ads | 3.1 | $8.6M | 65k | 132.72 | |
Pfizer (PFE) | 3.0 | $8.5M | 250k | 33.87 | |
Oncomed Pharmaceuticals | 3.0 | $8.3M | 725k | 11.43 | |
Celgene Corporation | 2.8 | $7.8M | 75k | 104.53 | |
Biogen Idec Inc option | 2.8 | $7.8M | 25k | 313.04 | |
Celgene Corp option | 2.8 | $7.8M | 75k | 104.53 | |
Medicines Company | 2.7 | $7.5M | 200k | 37.74 | |
Global Blood Therapeutics In | 2.7 | $7.5M | 325k | 23.05 | |
NuVasive | 2.4 | $6.7M | 100k | 66.66 | |
Biogen Idec (BIIB) | 2.2 | $6.3M | 20k | 313.05 | |
Aerie Pharmaceuticals | 2.2 | $6.2M | 165k | 37.74 | |
Lilly Eli & Co option | 2.1 | $6.0M | 75k | 80.27 | |
Global Blood Therapeutics In put | 1.9 | $5.2M | 100k | 52.49 | |
Mazor Robotics Ltd. equities | 1.9 | $5.2M | 200k | 25.87 | |
Alnylam Pharmaceuticals (ALNY) | 1.8 | $5.1M | 75k | 67.77 | |
Dermira | 1.8 | $5.1M | 150k | 33.82 | |
Gilead Sciences (GILD) | 1.7 | $4.7M | 60k | 79.12 | |
Merck & Co (MRK) | 1.7 | $4.7M | 75k | 62.41 | |
Glaukos (GKOS) | 1.6 | $4.5M | 120k | 37.74 | |
Exelixis (EXEL) | 1.6 | $4.5M | 350k | 12.79 | |
Healthways | 1.6 | $4.4M | 165k | 26.46 | |
Supernus Pharmaceuticals (SUPN) | 1.3 | $3.7M | 150k | 24.73 | |
Bristol Myers Squibb (BMY) | 1.2 | $3.5M | 65k | 53.92 | |
Merus N V (MRUS) | 1.2 | $3.4M | 200k | 16.75 | |
Gw Pharmaceuticals Plc ads | 1.2 | $3.3M | 25k | 132.72 | |
Cigna Corp | 1.2 | $3.3M | 25k | 130.32 | |
Minerva Neurosciences | 1.1 | $3.2M | 225k | 14.12 | |
Anthem (ELV) | 1.1 | $3.1M | 25k | 125.32 | |
Allscripts Healthcare Solutions (MDRX) | 1.1 | $3.0M | 225k | 13.17 | |
K2m Group Holdings | 1.1 | $2.9M | 165k | 17.78 | |
Spectranetics Corporation | 1.0 | $2.8M | 110k | 25.09 | |
Gw Pharmaceuticals Plc ads | 0.9 | $2.7M | 20k | 132.75 | |
Pacira Pharmaceuticals (PCRX) | 0.9 | $2.6M | 75k | 34.23 | |
Flamel Technologies | 0.9 | $2.5M | 200k | 12.40 | |
Alder Biopharmaceuticals | 0.9 | $2.5M | 75k | 32.77 | |
Aerie Pharmaceuticals Inc put | 0.9 | $2.5M | 65k | 37.74 | |
LHC | 0.9 | $2.4M | 65k | 36.88 | |
Impax Laboratories | 0.8 | $2.4M | 100k | 23.70 | |
Retrophin | 0.8 | $2.2M | 100k | 22.38 | |
BioScrip | 0.8 | $2.2M | 750k | 2.89 | |
PharMerica Corporation | 0.8 | $2.1M | 75k | 28.07 | |
Accelr8 Technology | 0.7 | $2.0M | 75k | 27.27 | |
Ionis Pharmaceuticals (IONS) | 0.7 | $1.8M | 50k | 36.64 | |
Acadia Healthcare (ACHC) | 0.6 | $1.7M | 35k | 49.54 | |
Kite Pharma | 0.6 | $1.7M | 30k | 55.87 | |
Ophthotech | 0.6 | $1.6M | 35k | 46.14 | |
Sarepta Therapeutics (SRPT) | 0.6 | $1.5M | 25k | 61.40 | |
Tandem Diabetes Care | 0.5 | $1.4M | 185k | 7.66 | |
Intersect Ent | 0.5 | $1.4M | 90k | 15.84 | |
Pharmerica Corp cmn | 0.5 | $1.4M | 50k | 28.08 | |
Invuity | 0.5 | $1.4M | 100k | 13.72 | |
Array BioPharma | 0.5 | $1.4M | 200k | 6.75 | |
Pacific Biosciences of California (PACB) | 0.5 | $1.3M | 150k | 8.96 | |
Five Prime Therapeutics Inc put | 0.5 | $1.3M | 25k | 52.48 | |
Acceleron Pharma | 0.5 | $1.3M | 35k | 36.20 | |
Boston Scientific Corporation (BSX) | 0.4 | $1.2M | 50k | 23.80 | |
Macrogenics (MGNX) | 0.4 | $1.2M | 40k | 29.90 | |
Gilead Sciences Inc option | 0.4 | $1.2M | 15k | 79.13 | |
Tenet Healthcare Corporation (THC) | 0.4 | $1.1M | 50k | 22.66 | |
Adma Biologics (ADMA) | 0.4 | $1.1M | 150k | 7.24 | |
Adaptimmune Therapeutics (ADAP) | 0.4 | $1.1M | 150k | 7.05 | |
Immunomedics | 0.3 | $975k | 300k | 3.25 | |
Chemocentryx | 0.3 | $906k | 150k | 6.04 | |
Pra Health Sciences | 0.3 | $848k | 15k | 56.53 | |
ACADIA Pharmaceuticals (ACAD) | 0.3 | $795k | 25k | 31.80 | |
Epizyme | 0.3 | $738k | 75k | 9.84 | |
Esperion Therapeutics Inc Ne | 0.2 | $693k | 50k | 13.86 | |
Esperion Therapeutics (ESPR) | 0.2 | $554k | 40k | 13.85 | |
Oncomed Pharmaceuticals | 0.2 | $572k | 50k | 11.44 | |
Oncomed Pharmaceuticals | 0.2 | $572k | 50k | 11.44 | |
Mei Pharma | 0.2 | $528k | 300k | 1.76 | |
Scynexis | 0.2 | $484k | 125k | 3.87 |